These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31468706)

  • 21. Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of Glioblastoma.
    Shang E; Nguyen TTT; Shu C; Westhoff MA; Karpel-Massler G; Siegelin MD
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32752193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury.
    Lei P; Baysa A; Nebb HI; Valen G; Skomedal T; Osnes JB; Yang Z; Haugen F
    Basic Res Cardiol; 2013 Jan; 108(1):323. PubMed ID: 23266787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses.
    Karpel-Massler G; Ishida CT; Bianchetti E; Shu C; Perez-Lorenzo R; Horst B; Banu M; Roth KA; Bruce JN; Canoll P; Altieri DC; Siegelin MD
    Cancer Res; 2017 Jul; 77(13):3513-3526. PubMed ID: 28522750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X Receptor activation delays chondrocyte hypertrophy during endochondral bone growth.
    Sun MM; Beier F
    Osteoarthritis Cartilage; 2014 Jul; 22(7):996-1006. PubMed ID: 24852699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].
    Wang R; Li R; Wen Q; Peng K; Tan X; Chen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):127-33. PubMed ID: 26932209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver X receptor agonist GW3965 dose-dependently regulates lps-mediated liver injury and modulates posttranscriptional TNF-alpha production and p38 mitogen-activated protein kinase activation in liver macrophages.
    Wang YY; Dahle MK; Steffensen KR; Reinholt FP; Collins JL; Thiemermann C; Aasen AO; Gustafsson JA; Wang JE
    Shock; 2009 Nov; 32(5):548-53. PubMed ID: 19295476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice.
    Park MC; Kwon YJ; Chung SJ; Park YB; Lee SK
    Rheumatology (Oxford); 2010 May; 49(5):882-90. PubMed ID: 20159908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes.
    Bal NB; Han S; Usanmaz SE; Kiremitci S; Sadi G; Uludag O; Demirel-Yilmaz E
    J Cardiovasc Pharmacol; 2019 Aug; 74(2):105-117. PubMed ID: 31397742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LXR agonist regulates the carcinogenesis of PCa via the SOCS3 pathway.
    Fu W; Yao J; Huang Y; Li Q; Li W; Chen Z; He F; Zhou Z; Yan J
    Cell Physiol Biochem; 2014; 33(1):195-204. PubMed ID: 24481266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of liver X receptor β-enhancing neurogenesis ameliorates cognitive impairment induced by chronic cerebral hypoperfusion.
    Sun T; Li YJ; Tian QQ; Wu Q; Feng D; Xue Z; Guo YY; Yang L; Zhang K; Zhao MG; Wu YM
    Exp Neurol; 2018 Jun; 304():21-29. PubMed ID: 29447944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.
    Pencheva N; Buss CG; Posada J; Merghoub T; Tavazoie SF
    Cell; 2014 Feb; 156(5):986-1001. PubMed ID: 24581497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
    Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
    Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Niemann-Pick C1-like 1 is required for an LXR agonist to raise plasma HDL cholesterol in mice.
    Tang W; Ma Y; Jia L; Ioannou YA; Davies JP; Yu L
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):448-54. PubMed ID: 18187667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.
    Matsunaga H; Tanaka S; Aihara A; Ogawa K; Matsumura S; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Arii S; Tanabe M
    Ann Surg Oncol; 2015 Sep; 22(9):3079-86. PubMed ID: 25524010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of liver X receptor protects inner retinal damage induced by N-methyl-D-aspartate.
    Zheng S; Yang H; Chen Z; Zheng C; Lei C; Lei B
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1168-80. PubMed ID: 25613943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCL-x
    Faqar-Uz-Zaman SF; Heinicke U; Meister MT; Vogler M; Fulda S
    Cancer Lett; 2018 Jan; 412():131-142. PubMed ID: 28947136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.
    Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J
    Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of liver X receptor signaling as a prevention and therapy for colon cancer.
    Chuu CP
    Med Hypotheses; 2011 May; 76(5):697-9. PubMed ID: 21333456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.